GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Goodness Growth Holdings Inc (OTCPK:GDNSF) » Definitions » Gross Margin %

Goodness Growth Holdings (Goodness Growth Holdings) Gross Margin % : 50.83% (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Goodness Growth Holdings Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Goodness Growth Holdings's Gross Profit for the three months ended in Mar. 2024 was $12.24 Mil. Goodness Growth Holdings's Revenue for the three months ended in Mar. 2024 was $24.09 Mil. Therefore, Goodness Growth Holdings's Gross Margin % for the quarter that ended in Mar. 2024 was 50.83%.


The historical rank and industry rank for Goodness Growth Holdings's Gross Margin % or its related term are showing as below:

GDNSF' s Gross Margin % Range Over the Past 10 Years
Min: 24.49   Med: 36.36   Max: 50.3
Current: 50.3


During the past 13 years, the highest Gross Margin % of Goodness Growth Holdings was 50.30%. The lowest was 24.49%. And the median was 36.36%.

GDNSF's Gross Margin % is ranked better than
56.14% of 985 companies
in the Drug Manufacturers industry
Industry Median: 47 vs GDNSF: 50.30

Goodness Growth Holdings had a gross margin of 50.83% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Goodness Growth Holdings was 0.00% per year.


Goodness Growth Holdings Gross Margin % Historical Data

The historical data trend for Goodness Growth Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Goodness Growth Holdings Gross Margin % Chart

Goodness Growth Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.49 34.81 36.36 41.42 50.04

Goodness Growth Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.87 46.20 53.48 49.87 50.83

Competitive Comparison of Goodness Growth Holdings's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Goodness Growth Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Goodness Growth Holdings's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Goodness Growth Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Goodness Growth Holdings's Gross Margin % falls into.



Goodness Growth Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Goodness Growth Holdings's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=44.1 / 88.133
=(Revenue - Cost of Goods Sold) / Revenue
=(88.133 - 44.029) / 88.133
=50.04 %

Goodness Growth Holdings's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=12.2 / 24.087
=(Revenue - Cost of Goods Sold) / Revenue
=(24.087 - 11.843) / 24.087
=50.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Goodness Growth Holdings  (OTCPK:GDNSF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Goodness Growth Holdings had a gross margin of 50.83% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Goodness Growth Holdings Gross Margin % Related Terms

Thank you for viewing the detailed overview of Goodness Growth Holdings's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Goodness Growth Holdings (Goodness Growth Holdings) Business Description

Traded in Other Exchanges
Address
885 West Georgia Street, Suite 2200 HSBC Building, Vancouver, BC, CAN, V6C 3E8
Goodness Growth Holdings Inc is a cannabis company whose mission is to provide safe access, quality products and value to its customers while supporting its local communities through active participation and restorative justice programs. It operates in one business segment, namely the Cannabis segment that cultivates, processes, and distributes medical and adult-use cannabis products in a variety of formats, as well as related accessories in Maryland, Minnesota, New Mexico, New York, and formerly Arizona, and Ohio.
Executives
Chicago Atlantic Manager, Llc 10 percent owner 420 N WABASH AVE STE 500, CHICAGO IL 60611
Chicago Atlantic Gp Holdings, Llc 10 percent owner 420 N WABASH AVE STE 500, CHICAGO IL 60611
Chicago Atlantic Group, Lp 10 percent owner 420 N WABASH AVE STE 500, CHICAGO IL 60611
Chicago Atlantic Group Gp, Llc 10 percent owner 420 N WABASH AVE STE 500, CHICAGO IL 60611
Chicago Atlantic Advisers, Llc 10 percent owner 420 NORTH WABASH AVENUE, SUITE 500, CHICAGO IL 60611
Chicago Atlantic Credit Opportunities, Llc 10 percent owner 420 N WABASH AVE STE 500, CHICAGO IL 60611
Joshua Rosen director 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Victor E. Mancebo director C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Christian Gonzales Ocasio officer: Chief Operating Officer C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Amber Holly Shimpa director, officer: Chief Administrative Officer C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Patrick Peters officer: EVP of Retail C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
J Michael Schroeder officer: General Counsel & CCO 3680 VICTORA STREET N, SHOREVIEW MN 55126
John Andrew Heller officer: Chief Financial Officer C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Ross Michael Hussey director C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Judd Theodore Nordquist director C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402